Pergolide: treatment of choice in Restless Legs Syndrome (RLS) and Nocturnal Myoclonus Syndrome (NMS). Longterm follow up on pergolide |
| |
| Authors: | J. Staedt H. Hünerjäger E. Rüther G. Stoppe |
| |
| Affiliation: | Department of Psychiatry, University of G?ttingen, Federal Republic of Germany, DE
|
| |
| Abstract: | ![]()
Summary. Pergolide has proven significantly superior to L-dopa plus peripheral decarboxylase inhibitor in short-term therapy of RLS/NMS. We now first present long-term follow-up sleep data showing its lastingly good effects after averagely 517 treatment days. Accepted December 15, 1997; received November 5, 1997 |
| |
| Keywords: | : Restless legs syndrome RLS nocturnal myoclonus syndrome NMS pergolide longterm treatment. |
| 本文献已被 SpringerLink 等数据库收录！ |
